Alpha Tau Medical (DRTS) director Alan Adler details share and option holdings
Rhea-AI Filing Summary
Alpha Tau Medical Ltd. director Alan Adler filed an initial ownership report showing his equity stake in the company. He directly holds 54,367 Ordinary Shares and 4,680 restricted share units, which will vest in full upon the earlier of one year from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to his continued service.
Adler also reports multiple option grants to acquire Ordinary Shares, with exercise prices ranging from $2.98 to $11.50 per share and expiration dates between 2028 and 2036. Some of these options are already fully vested, while others vest on the same future schedule tied to the March 9, 2026 date or the next Annual General Meeting.
Positive
- None.
Negative
- None.
Insider Trade Summary
10 transactions reported
Mixed
10 txns
Insider
Adler Alan
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Restricted Share Units | -- | -- | -- |
Holdings After Transaction:
Options — 228,796 shares (Direct);
Ordinary Shares — 54,367 shares (Direct);
Restricted Share Units — 4,680 shares (Direct)
Footnotes (3)
- F1. These ordinary shares represent restricted share units, which will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service.
- F2. These are options to acquire ordinary shares, which have fully vested as of the date hereof.
- F3. These are options to acquire ordinary shares, which options will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider position does Alan Adler report in Alpha Tau Medical (DRTS)?
Alan Adler, a director of Alpha Tau Medical, reports direct ownership of 54,367 Ordinary Shares. He also holds 4,680 restricted share units and several option grants over additional Ordinary Shares, reflecting his equity-based alignment with the company’s long-term performance.
What stock options does Alan Adler have in Alpha Tau Medical (DRTS)?
Alan Adler holds several option grants to acquire Alpha Tau Medical Ordinary Shares, with exercise prices from $2.98 to $11.50 per share. The options expire between 2028 and 2036, with some already fully vested and others vesting on a future schedule.
Are Alan Adler’s Alpha Tau Medical options fully vested?
Some of Alan Adler’s options are fully vested as of the reporting date, while others will vest in full upon the earlier of one year from March 9, 2026 or the next Annual General Meeting, provided he continues to serve the company.
What is the vesting condition for Alan Adler’s RSUs and some options at Alpha Tau Medical?
The RSUs and certain option grants vest in full on the earlier of one year starting March 9, 2026 or the next Annual General Meeting of Shareholders. Vesting is explicitly conditioned on Alan Adler’s continued service with Alpha Tau Medical.